This inventor holds 3 USPTO granted patents and 4 published patent applications. Top assignees: Genome and Company, Lactomason Co., Ltd., Other. Active years: 2021-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- YangJu, KR (2021)
- Seoul, KR (2022 - 2023)
Company Filing History:
2 out of 9 
2 out of 4 
1 out of 834,453 Years Active: 2021-2023
Title: Innovations of Han Soo Park in Obesity and Diabetes Treatment
Introduction
Han Soo Park is a notable inventor based in Seoul, South Korea. He has made significant contributions to the fields of health and medicine, particularly in the treatment and prevention of obesity and diabetes. With a total of three patents to his name, Park's work focuses on innovative strains of Lactobacillus that have promising health benefits.
Latest Patents
One of Han Soo Park's latest patents is for the Lactobacillus rhamnosus LM1019 strain and its composition for preventing and treating obesity or diabetes mellitus. This invention relates to the LM1019 strain (accession number KCCM12308P), which has been shown to reduce fat cells, neutral fats, subcutaneous fats, and cholesterol. As a result, it plays a crucial role in preventing and treating obesity. Additionally, the LM1019 strain helps lower blood glucose and insulin concentrations, thereby inhibiting insulin resistance and aiding in the prevention and treatment of diabetes mellitus. Another significant patent involves the LM1016 strain (KCCM12468P), which is useful for treating or preventing cardiovascular diseases, obesity, fatty liver, and diabetes. The compositions derived from this strain can be applied in medicines, health-functional foods, dairy products, fermented products, food additives, and animal feeds.
Career Highlights
Throughout his career, Han Soo Park has worked with various companies, including Genome and Company and Lactomason Co., Ltd. His innovative research and development efforts have positioned him as a key figure in the biotechnology sector, particularly in the area of health-related products.
Collaborations
Han Soo Park has collaborated with Chang Moo Lee, contributing to the advancement of research in his field. Their partnership has fostered innovation and development in health solutions.
Conclusion
Han Soo Park's contributions to the fields of obesity and diabetes treatment through his patented innovations highlight his role as a leading inventor in health biotechnology. His work continues to pave the way for new solutions in managing these prevalent health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile